Join our U.S. and European Regulatory and Healthcare teams as they discuss the latest regulatory developments shaping strategic investments across the U.S., UK, and EU.
During this session, we will provide in-depth insights on topical regulatory opportunities and challenges for the healthcare investment sector. Gain in-depth insight into how U.S. and European regulatory changes may impact the sector and how the new U.S. administration policies are creating investment opportunities. Explore effective strategies for successfully navigating the intricate and evolving global life sciences landscape.
Sidley Speakers
- Dr. Chris Boyle – Partner, Food, Drug and Medical Device (London)
- Meena Datta – Partner, Global Co-leader, Healthcare (Chicago)
- Maarten Meulenbelt – Partner, Head of European Life Sciences, Food, Drug and Medical Device (Brussels)
- Josefine Sommer – Partner, Food, Drug and Medical Device (Brussels)
- Becky Wood – Partner, Global Co-leader, Food, Drug and Medical Device, (Washington, D.C.), and Former Chief Counsel, U.S. Food and Administration, FDA
This Breakfast Briefing takes place just ahead of Sidley Healthcare Investment Conference 2025. To learn more about the conference, please click here.
